15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Lipocine Inc, 0 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $15.00 to $15.00, so the covering firms are broadly aligned. The average target of $15.00 sits 601% above the current $2.14. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.40 next quarter toward $-1.65 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Hold
Strong Buy00%
Buy00%
Hold1100%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Lipocine Inc.
As of Aug, 0 of 1 firms rate LPCN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LPCN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.40
Range $-0.40 – $-0.40 · 1 analysts · -5% YoY
Next period, 1 analysts expect Lipocine Inc to earn $-0.40 a share (range $-0.40 – $-0.40), versus $-0.42 a year earlier. Full-year consensus is $-1.55, growing to $-1.65 the year after.
REVENUE · NEXT QUARTER
$225.0K
Range $225.0K – $225.0K · 1 analysts · -80% YoY
Revenue is expected to reach $225.0K (range $225.0K – $225.0K), -80.4% year-over-year. Full-year consensus is $753.5K, rising to $1.1M next year.
Top analysts covering Lipocine Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LPCN.
#1
Yi Chen
HC Wainwright & Co. · Rank #276
Hold
No targeton LPCN
Overall win rate
33%
+ Follow
#2
SH
Scott Henry
Alliance Global Partners
Buy
$10.00+367.3% to target
Coverage
—
+ Follow
LPCN stock forecast FAQ
Is LPCN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 1 analyst ratings, 0 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover LPCN?+
1 analysts have an active rating on Lipocine Inc.
Who is the most accurate analyst covering LPCN?+
Among analysts who currently cover LPCN, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #276). Their current call is Hold.
What is Lipocine Inc's projected EPS for next quarter?+
The consensus estimate is $-0.40 per share (range $-0.40 – $-0.40) across 1 analysts. Full-year EPS is projected at $-1.55, rising to $-1.65 the following year.
How much revenue is Lipocine Inc expected to report next quarter?+
Consensus revenue is $225.0K (range $225.0K – $225.0K). Full-year revenue is projected at $753.5K, growing to $1.1M next year.
Have analysts been upgrading or downgrading LPCN lately?+
As of Aug, 0 of 1 firms rate LPCN a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LPCN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
